Novavax Inc (NVAX)
$13.61 -$0.91 (-6.31%) 4:37 PM 10/05/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$2.13B -
Day's Range
$13.36 - $14.70 -
Volume
7,256,137 -
52 Week Low / High
$3.53 - $23.86 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
NVAX's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 2
- Strong Buy
- 1
- Buy
- 2
- Hold
- 1
- Sell
- 0
- Strong Sell
- $20.60
- Target Price
Company News
-
Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development — Sep 25th, 2024
Ruxandra Draghia-Akli, MD, PhD brings more than 20 years of extensive clinical, corporate and global public health expertise to support Novavax's transition to an R&D-focused organization Dr. Draghia-Akli will be integral in strategically evaluating the Company's pipeline and opportunities...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$